MARY PASTERNACKI: Open Payments
NPI 1275690331 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 23 payments from 11 companies in 2025. Trend: 2023 $321 · 2024 $975 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $184 |
| Merz Pharmaceuticals, LLC | 2 | $52 |
| Eisai Inc. | 2 | $51 |
| EMD Serono, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $41 |
| Viatris Specialty LLC | 1 | $31 |
| GENZYME CORPORATION | 1 | $27 |
| Neurelis, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
Products named: BREZTRI, Xeomin, Leqembi, AIRSUPRA, QULIPTA, YUPELRI, VALTOCO, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
